FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant)

WAYNE, N.J., Aug. 7 /PRNewswire/ -- Today, Bayer HealthCare Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved a 3000 IU (international unit) vial size of Kogenate(R) FS , antihemophilic factor (recombinant). The new vial size offers greater co...

FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia

MONTGOMERY, Ala. and MORRISVILLE, N.C., Aug. 3 /PRNewswire/ -- Kowa Research Institute (KRI) based in Morrisville, NC and Kowa Pharmaceuticals America, Inc. (KPA), a privately-held specialty pharmaceutical company headquartered in Montgomery, AL, announced today that the U.S. ...

FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

TITUSVILLE, N.J., July 31 /PRNewswire/ -- The U.S. Food and Drug Administration today approved INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in adults. It is the first once-monthly, lon...

House Committee Approves Amendment Eliminating Cost-Sharing for Medicaid Preventive Services

Partnership for Prevention Led Coalition Backing Amendment WASHINGTON, July 31 /PRNewswire-USNewswire/ -- The House Energy and Commerce Committee on Friday unanimously approved an amendment to health reform legislation that would prohibit cost-sharing to Medicaid patients f...

FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension

SILVER SPRING, Md., July 30 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) announced today that the United States Food and Drug Administration (FDA) has approved TYVASO (treprostinil) Inhalation Solution for the treatment of pulmonary arterial hypertensi...

FDA Approves Sculptra(R)Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles

BRIDGEWATER, N.J., July 29 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) approved Sculptra(R)Aesthetic (injectable poly-L-lactic acid) for the correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and ...

Kaiser Permanente Approves $11 Million in Community Benefit Grants

OAKLAND, Calif., July 28 /PRNewswire/ -- Kaiser Permanente, one of America's leading health care providers and nonprofit health plans, announced today that it has approved more than $11 million in grants and donations to more than 700 nonprofit agencies nationwide in the second...

FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis

INDIANAPOLIS, July 23 /PRNewswire-FirstCall/ -- Today, Eli Lilly and Company (NYSE: LLY ) announced that the U.S. Food and Drug Administration (FDA) has approved a new use for its osteoporosis drug FORTEO((R)) [teriparatide (rDNA origin) injection] to treat osteoporosis associated...

American Academy of Orthopaedic Surgeons approves new guideline for the treatment of pediatric diaphyseal femur fractures

ROSEMONT, Ill. -- The American Academy of Orthopaedic Surgeons'(AAOS) Board of Directors approved a new clinical practice guideline for the treatment of pediatric diaphyseal femur fractures. Diaphyseal (the shaft of a long bone) fracture of the femur (the bone in the thigh) is a very common childh...

American Academy of Orthopaedic Surgeons Approves New Guideline for the Treatment of Pediatric Diaphyseal Femur Fractures

ROSEMONT, Ill., July 22 /PRNewswire-USNewswire/ -- The American Academy of Orthopaedic Surgeons'(AAOS) Board of Directors approved a new clinical practice guideline for the treatment of pediatric diaphyseal femur fractures . Diaphyseal (the shaft of a long bone) fracture of the femur ...

More>>

Approves in Medical Technology

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

TITUSVILLE, N.J., Aug. 3 /PRNewswire/ -- The U.S. Food and Drug Administration approved INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in adults on Friday, July 31, 2009. It is the first ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

EAST HANOVER, N.J., July 21 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved Tekturna HCT((R)) (aliskiren and hydrochlorothiazide) tablets as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals. Tek...

FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension

Conference Call to be Held at 9:00 a.m. Eastern Time Today, May 26, 2009 SILVER SPRING, Md., May 26 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) announced today that the United States Food and Drug Administration (FDA) has approved ADCIRCA(TM) (tadalafil) tablet...

FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia

ROCKVILLE, Md., May 6 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) announced today that the US Food and Drug Administration (FDA) has granted marketing approval of Fanapt(TM) (iloperidone) for the acute treatment of adult patients with schizophrenia. The approval was supp...

FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C

New use for PEGINTRON(TM) and REBETOL(R) offers certain patients a second chance to achieve treatment success KENILWORTH, N.J., March 11 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that the U.S. Food and Drug Administration (FDA) has approved new label...

FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation

WOODCLIFF LAKE, N.J., Dec. 14 /PRNewswire/ -- Eisai Corporation of North America today announced that the U.S. Food and Drug Administration (FDA) has approved LUSEDRA(TM) (fospropofol disodium) Injection, an intravenous sedative-hypnotic agent for monitored anesthesia care (MAC) sedation in adult ...

FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain

RARITAN, N.J., Nov. 21 /PRNewswire/ -- Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option. Today, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD), announced that the U.S. Food and Dru...

FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder

PHILADELPHIA, Nov. 20 /PRNewswire-FirstCall/ --GlaxoSmithKline (NYSE: GSK ) today announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA(R) (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immu...

FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes

BRIDGEWATER, N.J., Oct. 29 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) (insulin glulisine [rDNA origin] injection) to improve glycemic control in children (4 years and older) with diabetes mellitus. The approval...

FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A

Pivotal Data Show Prophylaxis Treatment with Kogenate FS Reduces the Risk of Joint Damage and Frequent Bleeds in Children with No Pre-Existing Joint Damage BERKELEY, Calif., Oct. 10 /PRNewswire/ -- Bayer HealthCare LLC announced today that the U.S. Food and Drug Administration (FDA) has appr...

Approves in Medical Dictionary

Phenylketonuria

...dlinePlus Encyclopedia: Phenylketonuria ... Phenylketonuria ... FDA approves Kuvan for Treatment of Phenylketonuria (PKU)(Food and Drug Administration...nuria ) is an inherited disorder that can cause mental retardation. ... FDA approves Kuvan for Treatment of Phenylketonuria (PKU), December 13, 2007. ... ...

Head lice

...o nine days into the first nymph stage, which ... Head lice — Comprehensive overview covers symptoms, causes, treatment, prevention. ... FDA approves benzyl alcohol lotion for the treatment of head lice . ... A lice infestation can be caused by head lice , pubic lice , or body lice ....

Antihypertensives

...ypertensive medical term. What does ... antihypertensive agent. Various drugs achieve their antihypertensive ... Antihypertensives : The FDA approves 2 new enzyme replacement products, Aldurazyme (laronidase) and Fabrazyme (agalsidase beta) Oakwood Healthcare System is a regional health care n...

Approves in Biological News

NSF approves $1.3M for OSU and OU microbes hunt

The National Science Foundation has approved a $1.3 million grant for researchers at Oklahoma State University and the University of Oklahoma to discover new kinds of microorganisms in natural habitats. The five-year grant will enable scientists to detect, identify, and isolate unique microorganis...

FDA approves Vidaza label expansion

Washington D.C. (August 21, 2008) The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to inform patients that the U.S. Food & Drug Administration (FDA) has expanded the label for VIDAZA (azacitidine) to include data from the AZA-001 trial, which found that Vidaza is the only...

Digimarc Board Approves $310 Million All-Cash Offer from L-1 Identity Solutions for Digimarc's ID Systems Business

Digimarc Unanimously Approves Offer from L-1 and Terminates Discussions with Safran STAMFORD, Conn., June 30 /PRNewswire-FirstCall/ -- L-1 Identity Solutions ("L-1") (NYSE: ID ), a leading provider of identity solutions and services, today announced that L-1 has s...

Court Approves Scheme of Arrangement

BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, May 22 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP)(NASDAQ: SHPGY ), the global specialty biopharmaceutical company, announces that the High Court approved the scheme of arrangement between Shire plc and its ordinary shareholders at a hea...

Health Canada approves cold and flu medicine

Health Canada, the Canadian government regulatory agency, has approved wide-ranging new health claims for COLD-fX®, the most popular cold/flu remedy in Canada. After an extensive review, the Natural Health Products Directorate (NHPD) ?a division of Health Canada responsible for evaluating the safe...

FDA approves first medical device using rutgers biomaterial

Rutgers scientists and TyRx Pharma, Inc., have announced the Food and Drug Administration's clearance of a new medical device for hernia repair that incorporates a biodegradable technology developed at the university. This action signals a paradigm shift in the application of biomaterials from perm...

FDA approves child-friendly AIDS medicine

A new website with a Global Information System will provide valuable information for assessing environmental hazards caused by Hurricane Katrina. The National Institute of Environmental Health Sciences (NIEHS), one of the National Institutes of Health, created the website to provide the most up-to-...

FDA approves more generic AIDS drugs

Experimenting with Arabidopsis, a fast-growing cousin of the humble mustard plant, scientists at the University of North Carolina at Chapel Hill got a big surprise while investigating how plants respond to attacks from disease organisms such as bacteria and viruses. "Contrary to what we thought w...

FDA Approves New Treatment for Chronic Hepatitis B

The Food and Drug Administration (FDA) announced the approval of Baraclude (entecavir) tablets and oral solution for the treatment of chronic hepatitis B in adults. Chronic hepatitis B is a serious disease caused by the hepatitis B virus (HBV) that attacks the liver. The virus can cause lifelong in...

Canada approves marijuana-based pain spray

Health Canada has approved Sativex® (Cannabis sativa L. extract) a new drug developed as adjunctive treatment for the symptomatic relief of neuropathic pain in adults with multiple sclerosis (MS). Canada becomes the first country in the world to approve Sativex, a novel prescription pharmaceutical ...

More>>

Approves in Biological Technology

EU Committee Approves New Food Applications for Martek's life'sDHA(TM)

COLUMBIA, Md., July 17 /PRNewswire-FirstCall/ -- DHA omega-3 innovator and maker of the life'sDHA(TM) brand of DHA, Martek Biosciences (Nasdaq: MATK ), announced today that it has received a unanimous positive vote from the Standing Committee On The Food Chain and Animal Health ...

EU Committee Approves New Food Applications for Martek's life'sDHA™

life'sDHA Now Approved for Use in Bakery Products, All Dairy Products, Cereal Bars, Beverages Columbia, MD (Vocus) July 16, 2009 -- DHA omega-3 innovator and maker of the life'sDHA ™ brand of DHA, Martek Biosciences, announced today that it has received a unanimo...

Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler

First and Only Collagen-Based Filler Proven To Last Through One Year HERZLIYA, Israel and SKILLMAN, N.J., June 8 /PRNewswire/ -- Ortho Dermatologics today announced that the U.S. Food and Drug Administration (FDA) approved a labeling supplement which includes efficacy and safety data through ...

FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

ADHD symptom control demonstrated from the first time point measured (1.5 hours) through 13 hours postdose PHILADELPHIA, June 1 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced that the US Food and Drug Adminis...

FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System

NATICK, Mass., May 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Liberte (R) Atom(TM) Paclitaxel-Eluting Coronary Stent System, a highly deliverable, next-g...

Arpida Annual General Meeting of Shareholders Approves All Board Proposals

REINACH, Switzerland, May 7 /PRNewswire-FirstCall/ -- The Annual General Meeting of Arpida Ltd (SIX: ARPN) has approved the proposals that were put forward by the Board of Directors. A total of 90 shareholders were present at the meeting that took place in Reinach today. 4,629,711 share...

Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Canadian Approval Is World's First Regulatory Approval for SIMPONI HORSHAM, Pa. and KENILWORTH, N.J., April 13 /PRNewswire-FirstCall/ Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP ) today announced that Health Canada has granted approval of SIMPONI (TM) (go...

FDA Approves Label Change for Non-Invasive Fibroid Treatment

TIRAT CARMEL, Israel, April 7 /PRNewswire/ -- InSightec Ltd. announced today that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate(R) 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable...

FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery

ISELIN, N.J., March 9 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, today announced that the U.S. Food and Drug Administration (FDA) has approved the Pre-market Approval (PMA)...

FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)

SYMBICORT provides a new, fast-acting(1) combination treatment option for millions of Americans with debilitating lung disease WILMINGTON, Del., Feb. 27 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN ) today announced that the U.S. Food and Drug Administration (FDA) has approved SYMBICO...

More>>

Approves in Biological Definition

Biotechnology

...is used to produce insulin and other medicine, in human form. (About 5% of diabetics are allergic to animal insulins available before) 1992 FDA approves of the first GM food from Calgene : "Flavr Savr" tomato 1999 Biotechnology program started at North Montgomery County Technical Career Center in ...

Approves in Biological Dictionary

Lumen

... has been written in Cocoa Touch, it has ... to detail and the colorful graphics make Lumen a joy to play. ... Lumen is very simple and ... FDA approves Lumen Biomedical's FiberNet Embolic Protection System for Carotid Artery Stenting ... Lumen Biomedical Receives FDA Clearance of Embolectomy ... ...